[go: up one dir, main page]

WO2007137135A3 - Analogues de roténone, méthode de préparation et d'utilisation - Google Patents

Analogues de roténone, méthode de préparation et d'utilisation Download PDF

Info

Publication number
WO2007137135A3
WO2007137135A3 PCT/US2007/069178 US2007069178W WO2007137135A3 WO 2007137135 A3 WO2007137135 A3 WO 2007137135A3 US 2007069178 W US2007069178 W US 2007069178W WO 2007137135 A3 WO2007137135 A3 WO 2007137135A3
Authority
WO
WIPO (PCT)
Prior art keywords
rotenone
analogs
preparation
present
tracers
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/US2007/069178
Other languages
English (en)
Other versions
WO2007137135A2 (fr
Inventor
James P O'neil
Brocklin Henry F Van
Nandanan Erathodiyil
Andrew R Gibbs
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of California Berkeley
University of California San Diego UCSD
Original Assignee
University of California Berkeley
University of California San Diego UCSD
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of California Berkeley, University of California San Diego UCSD filed Critical University of California Berkeley
Publication of WO2007137135A2 publication Critical patent/WO2007137135A2/fr
Publication of WO2007137135A3 publication Critical patent/WO2007137135A3/fr
Priority to US12/273,509 priority Critical patent/US8551448B2/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D493/00—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
    • C07D493/12—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains three hetero rings
    • C07D493/16—Peri-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/041—Heterocyclic compounds
    • A61K51/0412—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K51/0421—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic Table
    • C07F7/22—Tin compounds
    • C07F7/2208—Compounds having tin linked only to carbon, hydrogen and/or halogen

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Optics & Photonics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

Abstract

La présente invention concerne des analogues de roténone et des méthodes de fabrication et d'utilisation de ceux-ci. Lesdits analogues de roténone sont marqués par des isotopes monophotoniques et d'émission de positons et sont utiles dans des applications d'imagerie clinique en tant que traceurs pour mesurer la circulation sanguine cardiaque et détecter des régions d'ischémie.
PCT/US2007/069178 2006-05-18 2007-05-17 Analogues de roténone, méthode de préparation et d'utilisation Ceased WO2007137135A2 (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
US12/273,509 US8551448B2 (en) 2006-05-18 2008-11-18 Rotanone analogs: method of preparation and use

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US80133206P 2006-05-18 2006-05-18
US60/801,332 2006-05-18

Related Child Applications (1)

Application Number Title Priority Date Filing Date
US12/273,509 Continuation US8551448B2 (en) 2006-05-18 2008-11-18 Rotanone analogs: method of preparation and use

Publications (2)

Publication Number Publication Date
WO2007137135A2 WO2007137135A2 (fr) 2007-11-29
WO2007137135A3 true WO2007137135A3 (fr) 2008-04-03

Family

ID=38724021

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2007/069178 Ceased WO2007137135A2 (fr) 2006-05-18 2007-05-17 Analogues de roténone, méthode de préparation et d'utilisation

Country Status (1)

Country Link
WO (1) WO2007137135A2 (fr)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102336764B (zh) * 2011-06-21 2013-10-30 兰州大学 自旋标记鱼藤酮肟酯及其制备方法和用途
EP2731952B1 (fr) * 2011-07-13 2017-01-18 Nordion (Canada) Inc. Dérivés de roténone radio-marqués et leur utilisation en imagerie spect
KR101422189B1 (ko) * 2012-10-24 2014-07-22 한국원자력연구원 신규한 로테논 유도체 및 이를 유효성분으로 함유하는 비만 예방 및 치료용 약학적 조성물
CN103044440B (zh) * 2012-12-31 2015-11-18 深圳市华农生物工程有限公司 一种鱼藤酮临界萃取方法

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003086476A1 (fr) * 2002-04-08 2003-10-23 Biostream, Inc. Derives de rotenone a marquage au technetium, et procedes d'utilisation correspondants
US20050192458A1 (en) * 2002-04-30 2005-09-01 Goodman Mark M. Tumor imaging compounds

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003086476A1 (fr) * 2002-04-08 2003-10-23 Biostream, Inc. Derives de rotenone a marquage au technetium, et procedes d'utilisation correspondants
US20050192458A1 (en) * 2002-04-30 2005-09-01 Goodman Mark M. Tumor imaging compounds

Also Published As

Publication number Publication date
WO2007137135A2 (fr) 2007-11-29

Similar Documents

Publication Publication Date Title
WO2008010227A3 (fr) protocoles d'imagerie
GB0718967D0 (en) Peptide imaging agents
WO2007010534A3 (fr) Protocoles d'imagerie
BR112015012014A2 (pt) proteínas de ligação específicas duais penetrando a barreira hematoencefálica (bbb)
WO2008128049A3 (fr) Procédés d'administration de la tétrahydrobioptérine, compositions associées et procédés de mesure
ATE551073T1 (de) Markierte hgf-bindende peptide für bildgebung
WO2007109227A3 (fr) Collimation par fentes-lames
MX2013010012A (es) Analogos de octreotato radiomarcado como trazadores de tomografia por emision de positrones.
MY150757A (en) Click chemistry-derived cyclopeptide derivatives as imaging agents for integrins
WO2008033557A3 (fr) Peptidomimétiques cycliques dérivés de la chimie clic et utilisés en tant que marqueurs d'intégrine
WO2011015602A3 (fr) Biomarqueurs du cancer du poumon
PH12013500270A1 (en) Peptide radiotracer compositions
WO2009052970A3 (fr) Composés destinés à être utilisés dans le cadre d'imagerie, de diagnostic et/ou de traitement de maladies du système nerveux central ou de tumeurs
DE502007005902D1 (de) -methyl-19-nor-20- spirox-4-en-3-one), sowie diese enthaltende pharmazeutische präparate
TN2016000083A1 (en) Methods and tools relating to the administration of contrast medium
WO2007137135A3 (fr) Analogues de roténone, méthode de préparation et d'utilisation
WO2009134405A3 (fr) Nouveaux agents d’imagerie tep basés sur un substrat
WO2009045535A3 (fr) Derive de dasatinib marque au fluor 18 et utilisations associees
WO2009018175A3 (fr) Azapeptides cycliques en tant que marqueurs d'intégrine
WO2008133730A3 (fr) Analogues de roténone marqués
FI3058960T3 (fi) Syöpään kohdistuvan terapeuttisen vaikutuksen diagnostinen aine
WO2012040138A3 (fr) Nouveau radiotraceur
PH12013501017A1 (en) Compounds for use in imaging, diagnosing and/or treatment of diseases of the central nervous system
WO2008151003A3 (fr) Nouveau dérivé de rhodamine marqué au fluor 18 pour imagerie de perfusion myocardique avec homographie par émission de positron
WO2011109285A3 (fr) Marqueur de pronostic pour vascularité cryoglobulinémique et malignités à cellules b chez les patients infectés par le vhc

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 07783894

Country of ref document: EP

Kind code of ref document: A2

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 07783894

Country of ref document: EP

Kind code of ref document: A2